[Federal Register Volume 88, Number 47 (Friday, March 10, 2023)]
[Notices]
[Pages 15035-15036]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04890]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifiers: CMS-10728 and CMS-416]


Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Centers for Medicare & Medicaid Services, Health and Human 
Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is 
announcing an opportunity for the public to comment on CMS' intention 
to collect information from the public. Under the Paperwork Reduction 
Act of 1995 (the PRA), Federal agencies are required to publish notice 
in the Federal Register concerning each proposed collection of 
information (including each proposed extension or reinstatement of an 
existing collection of information) and to allow 60 days for public 
comment on the proposed action. Interested persons are invited to send 
comments regarding our burden estimates or any other aspect of this 
collection of information, including the necessity and utility of the 
proposed information collection for the proper performance of the 
agency's functions, the accuracy of the estimated burden, ways to 
enhance the quality, utility, and clarity of the information to be 
collected, and the use of automated collection techniques or other 
forms of information technology to minimize the information collection 
burden.

DATES: Comments must be received by May 9, 2023.

ADDRESSES: When commenting, please reference the document identifier or 
OMB control number. To be assured consideration, comments and 
recommendations must be submitted in any one of the following ways:
    1. Electronically. You may send your comments electronically to 
https://www.regulations.gov. Follow the instructions for ``Comment or 
Submission'' or ``More Search Options'' to find the information 
collection document(s) that are accepting comments.
    2. By regular mail. You may mail written comments to the following 
address: CMS, Office of Strategic Operations and Regulatory Affairs, 
Division of Regulations Development, Attention: Document Identifier/OMB 
Control Number: __, Room C4-26-05, 7500 Security Boulevard, Baltimore, 
Maryland 21244-1850.
    To obtain copies of a supporting statement and any related forms 
for the proposed collection(s) summarized in this notice, please access 
the CMS PRA website by copying and pasting the following web address 
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.

FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.

SUPPLEMENTARY INFORMATION: 

Contents

    This notice sets out a summary of the use and burden associated 
with the following information collections. More detailed information 
can be found in each collection's supporting statement and associated 
materials (see ADDRESSES).

CMS-10728 Value in Opioid Use Disorder Treatment Demonstration
CMS-416 Annual Early and Periodic Screening, Diagnostic and Treatment 
(EPSDT) Participation Report

    Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain 
approval from the Office of Management and Budget (OMB) for each 
collection of information they conduct or sponsor. The term 
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies 
to publish a 60-day notice in the Federal Register concerning each 
proposed collection of information, including each proposed extension 
or reinstatement of an existing collection of information, before 
submitting the collection to OMB for approval. To comply with this 
requirement, CMS is publishing this notice.

Information Collection

    1. Type of Information Collection Request: Extension of a currently 
approved collection; Title of Information Collection: Value in Opioid

[[Page 15036]]

Use Disorder Treatment Demonstration; Use: Value in Opioid Use Disorder 
Treatment (Value in Treatment) is a 4-year demonstration program 
authorized under section 1866F of the Social Security Act (Act), which 
was added by section 6042 of the Substance Use-Disorder Prevention that 
Promotes Opioid Recovery and Treatment for Patients and Communities Act 
(SUPPORT Act). The purpose of Value in Treatment, as stated in the 
statute, is to ``increase access of applicable beneficiaries to opioid 
use disorder treatment services, improve physical and mental health 
outcomes for such beneficiaries, and to the extent possible, reduce 
Medicare program expenditures.'' As required by statute, Value in 
Treatment was implemented January 1, 2021. Section 1866F(c)(1)(A)(ii) 
specifies that individuals and entities must apply for and be selected 
to participate in the Value in Treatment demonstration pursuant to an 
application and selection process established by the Secretary.
    Section 1866F(c)(2)(B)(iii) specifies that in order to receive CMF 
and performance-based incentive payments under the Value in Treatment 
program, each participant shall report data necessary to: monitor and 
evaluate the Value in Treatment program; determine if criteria are met; 
and determine the performance-based incentive payment. Form Number: 
CMS-10728 (OMB control number: 0938-1388); Frequency: Annually; 
Affected Public: Individuals and Households; Number of Respondents: 
388; Total Annual Responses: 388; Total Annual Hours: 282. (For policy 
questions regarding this collection contact Rebecca VanAmburg at 410-
786-0524.)
    2. Type of Information Collection Request: Extension of a currently 
approved collection; Title of Information Collection: Annual Early and 
Periodic Screening, Diagnostic and Treatment (EPSDT) Participation 
Report; Use: The collected baseline data is used to assess the 
effectiveness of state early and periodic screening, diagnostic and 
treatment (EPSDT) programs in reaching eligible children (by age group 
and basis of Medicaid eligibility) who are provided initial and 
periodic child health screening services, referred for corrective 
treatment, and receiving dental, hearing, and vision services. This 
assessment is coupled with the state's results in attaining the 
participation goals set for the state. The information gathered from 
this report, permits federal and state managers to evaluate the 
effectiveness of the EPSDT law on the basic aspects of the program. 
Form Number: CMS-416 (OMB control number 0938-0354); Frequency: Yearly; 
Affected Public: State, Local, or Tribal Governments; Number of 
Respondents: 56; Total Annual Responses: 56; Total Annual Hours: 1,512. 
For policy questions regarding this collection contact Mary Beth Hance 
at 410-786-4299.

    Dated: March 6, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and 
Regulatory Affairs.
[FR Doc. 2023-04890 Filed 3-9-23; 8:45 am]
BILLING CODE 4120-01-P